Series date: 
01/03/2020 - 7:30am to 12/18/2020 - 7:30am

Mayo Clinic is committed to taking care of our learners and staff as we address the COVID-19 situation. In order to help protect our communities, and out of an abundance of caution, the School of Continuous Professional Development (CPD) is suspending live courses and conferences through December 31, 2020.

At this time, CPD suggests suspending or changing delivery method for Regularly Scheduled Series (RSS) with more than 10 in-person attendees. See individual RSS sessions or any changes to dates, times and delivery methods.

DESCRIPTION
This series is held weekly on Friday, 7:30 - 8:30 a.m.

Consultants, fellows and visiting professors present a 45 minute discussion topic which is intended to be a comprehensive review after which there is a 10-15 minute period for questions.  These "state-of-the-art" lectures are directed at the faculty and fellow level.  

TARGET AUDIENCE
The audience is primarily the physicians in our division, but all members of the division, i.e. nurses, NP/PAs and allied health staff are encouraged to attend.  We advertise the Grand Rounds title and speaker name throughout the institution which allows other areas/divisions to attend if they wish.  

LEARNING OBJECTIVES
Upon conclusion of this program, participants should be able to:

  • Explain how to apply clinical practice updates to improve patient outcomes.
  • Critically review clinical and basic research literature using an evidence-based approach.
  • Debate if specific findings are relative and applicable to patient care. 


Accreditation Statement:

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Credit Statement(s): 
AMA

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed...

Relevent financial relationship(s) with industry: 
None 

No relevent financial relationship(s) with industry: 
Hatem Amer, M.D., Suzanne Norby, M.D., Kathy Hegna Zelinske

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

TRANSCRIPT
Any credit or attendance awarded from this series will appear on your Transcript.

COURSE DIRECTORS
Hatem Amer, M.D., Suzanne Norby, M.D.

QUESTIONS?
Contact
Kathy Hegna Zelinske at phone 6-1044.

Where did the idea for the course originate?: 
Minnesota

Sessions

Session Date
Nephrology/Hypertension Journal Club - Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy - January 3, 2020 01/03/2020 - 7:30am to 8:30am
Nephrology/Hypertension Journal Club - Increased Production and Reduced Urinary Buffering of Acid in Uric Acid Stone Formers is Ameliorated by Pioglitazone - January 10, 2020 01/10/2020 - 7:30am to 8:30am
Nephrology/Hypertension Journal Club - Epigenome-wide association studies identify DNA methylation associated with kidney function - January 17, 2020 01/17/2020 - 7:30am to 8:30am
Nephrology/Hypertension Journal Club - Lung Ultrasound–Guided Dry Weight Assessment and Echocardiographic Measures in Hypertensive Hemodialysis Patients: A Randomized Controlled Study - January 24, 2020 01/24/2020 - 7:30am to 8:30am
Nephrology/Hypertension Journal Club - Haploidentical hematopoietic cell and kidney transplantation for hematological malignancies and end-stage renal failure - January 31, 2020 01/31/2020 - 7:30am to 8:30am
N-H Journal Club - A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus - February 7, 2020 02/07/2020 - 7:30am to 8:30am
CANCELLED - N-H Journal Club - February 21, 2020 02/21/2020 - 7:30am to 8:30am
CANCELLED - N-H Journal Club February 28, 2020 02/28/2020 - 7:30am to 8:30am
N-H Journal Club Belatacept-Based Immunosuppression with Simultaneous Calcineurin Inhibitor Avoidance and Early Corticosteroid Withdrawal: A Prospective, Randomized Multicenter Trial March 6, 2020 03/06/2020 - 7:30am to 8:30am
N-H Journal Club - Addition of cyclic angiotensin - (1-7) to angiotensin converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy - March 13, 2020 03/13/2020 - 7:30am to 8:30am

Pages